KIDS ORTHOPEDIATRICS CORP revenue, earnings and financials
For the quarter ended June 30, 2026, ORTHOPEDIATRICS CORP reported revenue of $70.5M (up 15.4% from a year earlier), net income of −$7.16M and diluted EPS of −$0.30; over the last four quarters revenue was $253M and net income −$39.7M; for the fiscal year ended December 2025 revenue was $236M, up 15.4% on the year before.
KIDS annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $236M, gross profit $173M, operating income −$39.2M, net income −$39.6M (margin -16.8%), EPS −$1.69
- Fiscal year ended Dec 2024: revenue $205M, gross profit $149M, operating income −$35.0M, net income −$37.8M (margin -18.5%), EPS −$1.64
- Fiscal year ended Dec 2023: revenue $149M, gross profit $111M, operating income −$26.8M, net income −$21.0M (margin -14.1%), EPS −$0.92
- Fiscal year ended Dec 2022: revenue $122M, gross profit $90.7M, operating income −$25.4M, net income $1.26M (margin 1.0%), EPS $0.06
- Fiscal year ended Dec 2021: revenue $98.0M, gross profit $73.4M, operating income −$18.0M, net income −$16.3M (margin -16.6%), EPS −$0.84
KIDS quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $70.5M (up 15.4% year over year), net income −$7.16M, EPS −$0.30
- Quarter ended Mar 31, 2026: revenue $59.4M (up 13.3% year over year), net income −$10.7M, EPS −$0.45
- Quarter ended Dec 31, 2025 (from the annual report): revenue $61.6M (up 17.0% year over year), net income −$10.1M, EPS −$0.43
- Quarter ended Sep 30, 2025: revenue $61.3M (up 12.2% year over year), net income −$11.8M, EPS −$0.50
- Quarter ended Jun 30, 2025: revenue $61.1M (up 15.7% year over year), net income −$7.11M, EPS −$0.30
- Quarter ended Mar 31, 2025: revenue $52.4M (up 17.3% year over year), net income −$10.7M, EPS −$0.46
- Quarter ended Dec 31, 2024 (from the annual report): revenue $52.7M (up 40.0% year over year), net income −$16.1M, EPS −$0.70
- Quarter ended Sep 30, 2024: revenue $54.6M (up 36.5% year over year), net income −$7.92M, EPS −$0.34
- Quarter ended Jun 30, 2024: revenue $52.8M (up 33.5% year over year), net income −$6.03M, EPS −$0.26
- Quarter ended Mar 31, 2024: revenue $44.7M (up 41.5% year over year), net income −$7.81M, EPS −$0.34
- Quarter ended Dec 31, 2023 (from the annual report): revenue $37.6M (up 21.4% year over year), net income −$6.69M, EPS −$0.29
- Quarter ended Sep 30, 2023: revenue $40.0M (up 14.4% year over year), net income −$4.59M, EPS −$0.20
- Quarter ended Jun 30, 2023: revenue $39.6M (up 20.1% year over year), net income −$2.89M, EPS −$0.13
- Quarter ended Mar 31, 2023: revenue $31.6M (up 34.9% year over year), net income −$6.81M, EPS −$0.30
- Quarter ended Dec 31, 2022 (from the annual report): revenue $31.0M (up 24.9% year over year), net income −$7.85M, EPS −$0.32
- Quarter ended Sep 30, 2022: revenue $35.0M (up 39.4% year over year), net income $18.5M, EPS $0.87
- Quarter ended Jun 30, 2022: revenue $32.9M (up 23.3% year over year), net income −$333K, EPS −$0.02
- Quarter ended Mar 31, 2022: revenue $23.4M (up 9.1% year over year), net income −$9.10M, EPS −$0.47
- Quarter ended Dec 31, 2021 (from the annual report): revenue $24.8M, net income $72.0K, EPS $0.00
- Quarter ended Sep 30, 2021: revenue $25.1M, net income −$2.20M, EPS −$0.11
KIDS cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$4.85M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$27.0M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$27.0M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$21.8M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$13.1M, share buybacks n/a
KIDS balance sheet
- Jun 30, 2026: cash $17.0M, total assets $511M, total liabilities $168M, shareholders' equity $344M, long-term debt $99.5M
- Mar 31, 2026: cash $12.2M, total assets $502M, total liabilities $163M, shareholders' equity $339M, long-term debt $100M
- Dec 31, 2025: cash $19.6M, total assets $509M, total liabilities $162M, shareholders' equity $347M, long-term debt $99.8M
- Sep 30, 2025: cash $16.8M, total assets $493M, total liabilities $144M, shareholders' equity $349M, long-term debt $99.2M
- Jun 30, 2025: cash $44.6M, total assets $504M, total liabilities $148M, shareholders' equity $356M, long-term debt $97.0M
- Mar 31, 2025: cash $33.4M, total assets $470M, total liabilities $123M, shareholders' equity $347M, long-term debt $73.0M
- Dec 31, 2024: cash $43.8M, total assets $473M, total liabilities $119M, shareholders' equity $355M, long-term debt $73.0M
- Sep 30, 2024: cash $51.0M, total assets $489M, total liabilities $118M, shareholders' equity $371M, long-term debt $72.5M
What is KIDS's revenue?
ORTHOPEDIATRICS CORP reported $253M of revenue over its last four quarters, through June 30, 2026.
Is KIDS profitable?
No. ORTHOPEDIATRICS CORP lost $39.7M over the last four quarters.
What is KIDS's EPS?
Diluted earnings per share over the last four quarters were −$1.68; −$0.30 in the latest quarter.